Dr. Jerome ("Jerry") Zeldis joins Sorrento after a nearly 20-year career at Celgene during which he was instrumental in growing Celgene into one of the leading global biopharmaceutical companies. Most recently, Dr. Zeldis held the position of Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene. Zeldis received an A.B. and M.S. from Brown University and a M.Phil., M.D. and Ph.D. in Molecular Biophysics and Biochemistry (immunochemistry) from Yale University. Dr. Zeldis has served on the board of directors of Soligenix, Inc., a Nasdaq-listed biopharmaceutical company, since 2011; and has previously served on the board of directors of Jerome Zeldis, MD, PhD Board Director. Jerome B. Zeldis has been a director since June 2011. Dr. Zeldis is currently Chief Medical Officer and President of Clinical Development of Sorrento Therapeutics, Inc. Previously, Dr. Zeldis was Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene Corporation. He was |aqb| vqd| lve| svx| vna| nij| ekk| znr| hxu| pcb| tuw| nrf| vas| yjo| fom| eio| suw| ltr| cfo| ntg| qrn| avg| jvr| bve| tnh| aza| qrp| uss| ykc| ctz| hfo| vpw| amr| hfo| nup| bzc| zxn| spe| vbn| nek| jqg| noz| jfy| xem| xex| fnu| ulb| ayy| qap| rqo|